InvestorsHub Logo
Followers 1
Posts 74
Boards Moderated 0
Alias Born 10/24/2017

Re: None

Friday, 10/26/2018 5:52:45 AM

Friday, October 26, 2018 5:52:45 AM

Post# of 1011

MGC Pharmaceuticals Ltd (ASX: MXC or “the Company”) has today published its
Appendix 4C for the three-months ended 30 September 2018 and provides an overview
of its operational highlights for the period.
Operational Update
The Company achieved a number of significant milestones during the quarter on its path
towards becoming a world-leading pure Bio-Pharma company and demonstrating its full
seed-to-pharma capabilities.